Dose escalation phase (titration) Tirzepatide titration (dose escalation) typically follows this schedule: Month 2: 4-6 mg once weekly Month 3: 6-8 mg once weekly Month 4: If tolerated, increase to 8-10 mg once weekly Month 5: If the dosage needs to be escalated further, increase to 10-12 mg once weekly Month 6 and onward: If the dosage needs to be escalated further, increase to 12-14 mg once weekly The maximum dosage is typically 14 mg once weekly if further glycemic control or weight loss is required
Patient Experiences with GHK-Cu Users report smoother texture and glow after 8-12 weeks
Lancet (London, England) , 406(10522), 29272944
Secondary outcomes commonly include the individual components of the primary outcomes, all-cause mortality, and time to first occurrence of hospitalization for HF, angina, or acute coronary syndrome
Nature Communications , 2025
Yerrington prior to treatment